ISSN 1662-4009 (online)

ey0016.13-1 | Diabetes | ESPEYB16

13.1. Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial

PC Rockers , RO Laing , PG Ashigbie , MA Onyango , CK Mukiira , VJ Wirtz

Lancet Glob Health 2019;7: e492–502. DOI: 10.1016/S2214-109X(18)30563-1• The authors evaluated the effect of a Novartis programme that provides metformin at a wholesale price of US$1 per month in Kenya.• This cluster-randomized controlled trial significantly increased the availability of metformin at health facilities, but not at patient househ...